Navigation Links
C-Sections Linked to Doubled Risk for Blood Clots
Date:8/26/2011

FRIDAY, Aug. 26 (HealthDay News) -- The risk of thromboembolism -- a potentially fatal condition in which blood clots block blood flow causing damage to the organs -- is higher during pregnancy, experts warn.

And having a Caesarean section nearly doubles that risk, according to experts at the American College of Obstetricians and Gynecologists. As a result, the group issued a new recommendation that all women having a C-section wear inflatable compression devices on their legs at the time of delivery to prevent clots from forming. In more risky cases, the group advised that women also receive anti-clotting medications (anticoagulants).

"VTE [venous thromboembolism] is a major contributor to maternal mortality in this country. The risk of VTE is increased during pregnancy and the consequences can be severe," Dr. Andra H. James, who helped develop the guidelines, said in a college news release. "It's important for ob-gyns to adopt these recommendations to help reduce maternal deaths."

VTE in pregnancy usually affects the deep veins of the left leg. Most women who develop clots in their lower legs will experience pain or swelling there, the authors noted.

Clots could also travel to the lungs resulting in a pulmonary embolism. Symptoms of this other potentially deadly condition include sudden shortness of breath, chest pain and coughing.

Pregnant women are at greater risk for VTE due to certain physiological changes they experience, including:

  • Blood that clots more easily
  • Slower blood flow
  • Compression of pelvic and other veins
  • Decreased mobility

In addition, women who have high blood pressure, a personal history of VTE or excessive clotting, as well as those who are obese or smokers are also at higher risk for the condition.

"Fitting inflatable compression devices on a woman's legs before cesarean delivery is a safe, potentially cost-effective preventive intervention," explained James. "Inflatable compression sleeves should be left in place until a woman is able to walk after delivery or -- in women who had been on blood thinners during pregnancy -- until anticoagulation medication is resumed."

The ob-gyn group pointed out that emergency c-sections are the exception. In these cases, delivery should not be delayed for the placement of compression devices.

Only women at particularly high risk for VTE should be given anti-clotting medication, the experts noted in the news release. This includes those with a history of VTE during pregnancy, a history of excessive clotting, and women at high risk for inherited clotting disorders. All women who've had c-sections, however, should continue to be monitored for VTE following delivery, the group added.

"Because half of VTE-related maternal deaths occur during pregnancy and the rest during the postpartum period, ongoing patient assessment is imperative," James concluded. "While warning signs in some women may be evident early in pregnancy, others will develop symptoms that manifest later in pregnancy or after the baby is born."

The guidelines will be published in a Practice Bulletin in the September issue of Obstetrics & Gynecology.

More information

The U.S. National Heart, Lung, and Blood Institute provides more information on thromboembolism.

-- Mary Elizabeth Dallas

SOURCE: American College of Obstetricians and Gynecologists, news release, Aug. 22, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. C-Sections Continue 12-Year Climb: U.S. Report
2. Study finds high rate of c-sections after pelvic fractures
3. C-Sections May Raise Celiac Disease Risk in Offspring
4. Panel Finds Many Women Can Avoid Repeat C-Sections
5. Lower socioeconomic status linked with heart disease despite improvements in other risk factor
6. Starvation in Youth Linked to Heart Risk in Adulthood
7. Tight Communities Can Lower Violence Linked to Liquor Stores
8. Decline in Hormone Therapy Linked to Fewer Mammograms
9. Drop in hormone therapy use linked with drop in mammogram rates
10. Metabolic Syndrome Linked to Kidney Disease
11. Scientists show how gene variant linked to ADHD could operate
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
C-Sections Linked to Doubled Risk for Blood Clots 
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... ... Cal Dining at the University of California Berkeley, and other leading institutions in ... the buying power of institutions to change the way animals are raised for ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: